The SARS-CoV-2–neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

OriginalsprogEngelsk
TidsskriftKidney International
Vol/bind100
Udgave nummer5
Sider (fra-til)1129-1131
ISSN0085-2538
DOI
StatusUdgivet - nov. 2021

Bibliografisk note

Funding Information:
The study was supported by The Novo Nordisk Foundation , grant NNF20SA0062931 .

Citationsformater